STONKWHISPER
← Back to Intel
Insider ActivityAUPH

TANG KEVIN, Chief Executive Officer at Aurinia Pharmaceuticals Inc., bought $3.1M of AUPH

Updated Jun 17, 2026
TANG KEVIN Chief Executive Officer
Aurinia Pharmaceuticals Inc. · $AUPH
$3.1M Total Value
206,005 Shares Traded
$15.28 Price / Share
13,044,106 Shares Owned After
2026-06-02 Filing Date

Transaction Details

InsiderTANG KEVIN
TitleChief Executive Officer
CompanyAurinia Pharmaceuticals Inc.
TickerAUPH
Transaction TypePurchase
Transaction Date2026-06-02
Shares Traded206,005
Price Per Share$15.28
Total Value$3.1M
Filed Date2026-06-02
Accession Number0001178579-26-000004

Ownership Context

Shares Owned After Transaction13,044,106
Ownership TypeIndirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001178579-26-000004

Other Insider Trades — AUPH

Other Trades by TANG KEVIN

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for AUPH — Aurinia Pharmaceuticals Inc. →

Track AUPH insider activity in real time on The Wire →

Get alerts when TANG KEVIN files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 17, 2026 at 07:03 UTC

Want real-time data? Access The Wire for live sentiment tracking.